J 2025

A normal electrocardiogram indicates a better prognosis in patients with moderate to very severe chronic obstructive pulmonary disease

KULIROVA, Martina; Miroslav SOLAR; Michal KOPECKY; Barbora NOVOTNA; Marek PLUTINSKÝ et al.

Základní údaje

Originální název

A normal electrocardiogram indicates a better prognosis in patients with moderate to very severe chronic obstructive pulmonary disease

Autoři

KULIROVA, Martina; Miroslav SOLAR; Michal KOPECKY; Barbora NOVOTNA; Marek PLUTINSKÝ; Kristián BRAT; Libor FILA; Petr VANIK; Pavlina MUSILOVA; Tomas DVORAK; Petr SAFRANEK; Michal SVOBODA a Vladimir KOBLIZEK

Vydání

Nature Scientific Reports, BERLIN, NATURE PORTFOLIO, 2025, 2045-2322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.900 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00140724

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Chronic obstructive pulmonary disease; Electrocardiography; Mortality; Prognosis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 3. 2025 08:33, Mgr. Tereza Miškechová

Anotace

V originále

The role of electrocardiography (ECG) in predicting mortality in patients with chronic obstructive pulmonary disease (COPD) has not been sufficiently established. Research question: Is a normal ECG associated with a better prognosis than an abnormal ECG in patients with COPD? ECG parameters were assessed in patients enrolled in the Czech Multicenter Research Database of COPD. We assessed ECGs from baseline (August 2013) until December 31, 2019, or until death. The primary endpoint was 5-year overall survival depending on the ECG findings. A total of 300 subjects were enrolled in the study and 143 died during follow-up. This multicenter noninterventional observational prospective study revealed a significant difference in 5-year overall survival between COPD patients with normal ECGs and those with prognostically significant or other ECG abnormalities (76.8%, 38.2%, and 63.4%, respectively; P < 0.001). Patients with prognostically significant ECG abnormalities had a 2.537-fold greater mortality risk at 5 years than those with normal ECGs. In the COPD setting, patients with normal ECGs had a better prognosis than those with prognostically significant abnormalities suggesting that ECG may be a valuable tool for predicting mortality risk in these patients.

Návaznosti

90249, velká výzkumná infrastruktura
Název: CZECRIN IV